FDA Adverse Event Malfunction Summary report: N

ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER

MDR report key: 5461692 · Received February 25, 2016

Report

Report Number
2432235-2016-00094
Event Type
Malfunction
Date Received
February 25, 2016
Date of Event
December 23, 2015
Report Date
February 4, 2016
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC.
Product Code
GKZ
PMA / PMN Number
K102644
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER STATED SHE FOLLOWED THE ADVIA 2120 OPERATOR GUIDE INSTRUCTIONS AND COVERED THE AUTOSAMPLER NEEDLE WITH THE RED NEEDLE COVER IMMEDIATELY AFTER REMOVING THE CENTERING COLLAR ON THE ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER INSTRUMENT. THE CUSTOMER DID NOT RECEIVE ANY TREATMENT BEYOND FIRST AID FOR THE NEEDLESTICK INJURY TO THEIR FINGER. SIEMENS HEALTHCARE DIAGNOSTICS INC. HAS DETERMINED THAT THE CAUSE OF THE NEEDLESTICK INJURY TO THE CUSTOMER'S FINGER ON THE ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER INSTRUMENT IS OPERATOR'S TECHNIQUE WHEN PERFORMING THE CENTERING COLLAR MAINTENANCE ON THE INSTRUMENT.

Description of Event or Problem · 1

THE CUSTOMER SUSTAINED A NEEDLESTICK INJURY TO THE FINGER WHILE PERFORMING THE CENTERING COLLAR MAINTENANCE PROCEDURE ON THE ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER INSTRUMENT. THE CUSTOMER WENT TO EMPLOYEE HEALTH AND THEN TO THEIR EMERGENCY ROOM TO BE SEEN AND DECLINED ANY MEDICATION. THE FINGER WAS WASHED AND A BANDAID WAS APPLIED. THERE ARE NO KNOWN REPORTS OF ADVERSE HEALTH CONSEQUENCES DUE TO THE CUSTOMER SUSTAINING A NEEDLESTICK INJURY WHILE PERFORMING THE CENTERING COLLAR MAINTENANCE PROCEDURE ON THE ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER INSTRUMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
118401 ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER GKZ SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA 2120 WITH DUAL ASPIRATE AUTOSAMPLER

Patients

Seq Age Sex Outcome Treatment
1 56 YR